Protagonist Therapeutics, Inc - 10-Q Filing
Protagonist Therapeutics reports third quarter 2026 financial results and updates on Takeda and Janssen collaboration agreements.
Tickers: $PTGX
Protagonist Therapeutics reports third quarter 2026 financial results and updates on Takeda and Janssen collaboration agreements.
Tickers: $PTGX